Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Orthocell.
RELATED STOCKHEAD STORIES
Health & Biotech
China is about to grant patents like never before, and these ASX stocks have already got some
Health & Biotech
ASX Health Stocks: Amplia begins Phase 2 trial for pancreatic cancer, while Avecho commences Phase 1 of cannabis gel
News
Closing Bell: The ASX makes a strong start to August, closes 1.3% higher
Health & Biotech
ASX Health Stocks: Hydrix implants world’s first Guardian heart attack alert system
Health & Biotech
ScoPo’s Powerplays: ASX biotech IPOs show ‘money is out there’; Virtus to benefit from rise in IVF
Stockhead TV
V-Con: Talking medical innovations and breakthrough treatments with ASX biotechs
Health & Biotech
New breakthrough in stem cells research paves the way for ASX regenerative medicine stocks
News
Last Orders: ASX finishes in the green, but there was a huge gap between the best & worst sectors
News
Last Orders: ASX Small caps gain 2.2 per cent
Health & Biotech
Broken bones are no pretty picture but these ASX stocks help you diagnose or fix them
News
Last Orders: What you might have missed on the ASX today
Health & Biotech
Orthocell jumps again after dental membrane approved in USA
News
10 at 10: These ASX stocks are conquering extremes this morning
News
Last Orders: What you might have missed on the ASX today
Health & Biotech
Orthocell shares spike after more positive clinical data from its nerve regeneration study
News
Rise and Shine: What you need to know before the ASX opens
News